SCHEMBL8871406

SCHEMBL8871406

COC(=O)CCC(=O)Nc1ccc2ncnc(Nc3cccc(C)c3)c2c1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.66
ERBB2 P04626 5/20 0.66
GMPS P49915 1/20 0.62
HDAC3 O15379 1/20 0.58
HDAC4 P56524 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC7 Q8WUI4 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC10 Q969S8 1/20 0.58
HDAC11 Q96DB2 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
HDAC9 Q9UKV0 1/20 0.58
HDAC5 Q9UQL6 1/20 0.58
ALDH1A1 P00352 1/20 0.58
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
ROCK2 O75116 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354580 0.85 EGFR (0.78) EGFRERBB2GMPS
SCHEMBL8871192 0.85 EGFR (0.60) EGFRERBB2GMPSALDH1A1MAPT
SCHEMBL8870629 0.84 EGFR (0.69) EGFRERBB2GMPS
SCHEMBL2100347 0.83 EGFR (0.77) EGFRERBB2
SCHEMBL13755813 0.82 EGFR (0.69) EGFRERBB2ALDH1A1HPGD
SCHEMBL2101667 0.82 EGFR (0.74) EGFRERBB2ALDH1A1MAPTHPGD
SCHEMBL8870714 0.81 EGFR (0.74) EGFRERBB2
SCHEMBL13755817 0.81 EGFR (0.74) EGFRERBB2ALDH1A1MAPTHPGD
SCHEMBL259181 0.80 MEN1 (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2100939 0.80 EGFR (0.68) EGFRERBB2GMPSALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 US disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 US disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 EP disclosed